SynthesisFrontiers in psychiatry2019
Individualized Prediction of Transition to Psychosis in 1,676 Individuals at Clinical High Risk: Development and Validation of a Multivariable Prediction Model Based on Individual Patient Data Meta-Analysis.
Open access · goldAbstract readSystematic Review
In one paragraph
Synthesis in Frontiers in psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 3 pooled it
3.6field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 3 syntheses or guidelines pooled it, 38 citations in OpenAlex.
- Prediction model developed on the basis of meta-analysis in the field of medicine: a systematic survey and methodological summaries.BMC medical research methodology · 2025Pooled it
- Predictors of transition in patients with clinical high risk for psychosis: an umbrella review.Translational psychiatry · 2023Pooled it
- Implementing Precision Psychiatry: A Systematic Review of Individualized Prediction Models for Clinical Practice.Schizophrenia bulletin · 2021Pooled it
- Using Large Language Models to Measure Symptom Severity Scores in Patients At-Risk for Schizophrenia.Schizophrenia bulletin · 2026Article
- Lived Experiences and Engagement in an Exercise Program for People with Resistant Major Depression: TRACE-RMD Study.Healthcare (Basel, Switzerland) · 2026Article
- The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program.Schizophrenia (Heidelberg, Germany) · 2025Article
- Gene Variant Related Neurological and Molecular Biomarkers Predict Psychosis Progression, with Potential for Monitoring and Prevention.International journal of molecular sciences · 2024Article
- Are factors that predict conversion to psychosis associated with initial transition to a high risk state? An adolescent brain cognitive development study analysis.Schizophrenia research · 2024Article
- Development and temporal validation of a clinical prediction model of transition to psychosis in individuals at ultra-high risk in the UHR 1000+ cohort.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2024Article
- Risk of Psychosis Among Individuals Who Have Presented to Hospital With Self-harm: A Prospective Nationwide Register Study in Sweden.Schizophrenia bulletin · 2024Article
- Adverse outcome analysis in people at clinical high risk for psychosis: results from a 2-year Italian follow-up study.Social psychiatry and psychiatric epidemiology · 2024Article
- Psychotic disorders as a framework for precision psychiatry.Nature reviews. Neurology · 2023Review
- Development and validation of a prediction model for rehospitalization among people with schizophrenia discharged from acute inpatient care.Frontiers in psychiatry · 2023Article
- Early cognitive comorbidities before disease onset: A common symptom towards prevention of related brain diseases?Heliyon · 2022Review
- How can we obtain truly translational mouse models to improve clinical outcomes in schizophrenia?Disease models & mechanisms · 2022Article
- Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis.Schizophrenia bulletin · 2022Article
- Negative Symptom Domains in Children and Adolescents at Ultra-High Risk for Psychosis: Association With Real-Life Functioning.Schizophrenia bulletin open · 2022Article
- Surface area in the insula was associated with 28-month functional outcome in first-episode psychosis.NPJ schizophrenia · 2021Article
- Momentary Manifestations of Negative Symptoms as Predictors of Clinical Outcomes in People at High Risk for Psychosis: Experience Sampling Study.JMIR mental health · 2021Article
- Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: a meta-analysis.EClinicalMedicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
34 authors at 20 institutions in 10 countries.
Aaltsje MaldaGGZ Friesland Mental Health Institute, Leeuwarden, Netherlands.
Nynke BoonstraGGZ Friesland Mental Health Institute, Leeuwarden, Netherlands.
Hans BarfNHL Stenden University of Applied Sciences, Leeuwarden, Netherlands.
Steven de JongLentis Psychiatric Institute, Groningen, Netherlands.
Andre AlemanUniversity of Groningen, Groningen, Netherlands.
Jean AddingtonDepartment of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Marita PruessnerPrevention and Early Intervention Program for Psychosis, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.
Dorien NiemanAmsterdam University Medical Centers, Location AMC, Department of Psychiatry, Amsterdam, Netherlands.
Lieuwe de HaanAmsterdam University Medical Centers, Location AMC, Department of Psychiatry, Amsterdam, Netherlands.
Anthony MorrisonDivision of Psychology and Mental Health, University of Manchester, Manchester, United Kingdom.
Anita Riecher-RösslerUniversity of Basel Psychiatric Hospital, Basel, Switzerland.
Erich StuderusUniversity of Basel Psychiatric Hospital, Basel, Switzerland.
Stephan RuhrmannDepartment of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany.
Frauke Schultze-LutterDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
Suk Kyoon AnDepartment of Psychiatry, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Shinsuke KoikeUniversity of Tokyo Institute for Diversity and Adaptation of Human Mind (UTIDAHM), Tokyo, Japan.
Kiyoto KasaiUniversity of Tokyo Institute for Diversity and Adaptation of Human Mind (UTIDAHM), Tokyo, Japan.
Barnaby NelsonOrygen, The National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia.
Patrick McGorryOrygen, The National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia.
Stephen WoodOrygen, The National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia.
Ashleigh LinTelethon Kids Institute, The University of Western Australia, Perth, WA, Australia.
Alison Y YungOrygen, The National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia.
Magdalena Kotlicka-AntczakDepartment of Affective and Psychotic Disorders, Medical University of Lodz, Lodz, Poland.
Marco ArmandoChild and Adolescence Neuropsychiatry Unit, Department of Neuroscience, Children Hospital Bambino Gesù, Rome, Italy.
Stefano VicariDepartment of Psychiatry, Tohoku University Hospital, Sendai, Japan.
Masahiro KatsuraDepartment of Psychiatry, Tohoku University Hospital, Sendai, Japan.
Kazunori MatsumotoDepartment of Psychiatry, Tohoku University Hospital, Sendai, Japan.
Sarah DurstonNICHE Lab, Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center, Utrecht, Netherlands.
Tim ZiermansAmsterdam University Medical Centers, Location AMC, Department of Psychiatry, Amsterdam, Netherlands.
Lex WunderinkGGZ Friesland Mental Health Institute, Leeuwarden, Netherlands.
Helga IsingDepartment of Clinical Psychology, VU University, Amsterdam, Netherlands.
Mark van der GaagDepartment of Clinical Psychology, VU University, Amsterdam, Netherlands.
Paolo Fusar-PoliEarly Psychosis: Interventions and Clinical-detection (EPIC) lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Gerdina Hendrika Maria PijnenborgUniversity of Groningen, Groningen, Netherlands.
Amsterdam University Medical Centers · NLThe University of Melbourne · AUGreater Manchester Mental Health NHS Foundation Trust · GBStenden University of Applied Sciences · NLThe University of Tokyo · JPTohoku University Hospital · JPUniversity Medical Center Groningen · NLUniversity of Basel · CHUniversity of Groningen · NLHeinrich Heine University Düsseldorf · DEKing's College London · GBLentis · NLMedical University of Lodz · PLParnassia Groep · NLThe Kids Research Institute Australia · AUTohoku University · JPUniversity Medical Center Utrecht · NLUniversity of Calgary · CAUniversity of Cologne · DEUniversity of Geneva · CH
Funding
Medical Research Council G0500264Medical Research Council MC_PC_16048
Abstract
PubMed holds no abstract for this paper.
Indexed as
clinical high riskindividual patient data meta-analysisprognosispsychosisrisk predictionschizophrenia
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.